Tunisian Lung Cancer Study

Clinical Observational Study on Tunisian Lung Cancer

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06934499

Acronym

LUNG-TUN

Enrollment

1334

Registered

2025-04-18

Start date

2025-05-02

Completion date

2026-10-30

Last updated

2025-06-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pulmonary Cancer

Keywords

Pulmonary Cancer, Registry, Tunisia

Brief summary

This is a prospective, multicenter, observational, national study. Eligible patients will be recruited consecutively among subjects with proven lung cancer, including any disease stage withclinical, therapeutic and evolutive discription.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Age more than 18 years * Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date * Informed consent

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Diagnostic delay	Day 1	Delay to set the pulmonary cancer diagnosis
Survival	12 months	Overall survival
Relapse	12 months	Time to relapse

Secondary

Measure	Time frame	Description
Recommendation Compliance	Day 1	Compliance to national and international guidance of pulmonary cancer management

Other

Measure	Time frame	Description
Multidisciplinary Consultation Meetings	12 months	Number of Multidisciplinary Consultation Meetings

Countries

Tunisia

Contacts

Primary ContactSoraya Fenniche, MD

soraya.fenniche@yahoo.fr+216 98 586 490

Backup ContactNesrine Mejri, MD

nesrinemejriturki2@gmail.com+216 97 429 933

Outcome results